Results
1 -
10 of
46
(Click
here to explore results)
Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies, Chapter 6 New Drug Design and Therapeutic Development for Weight Reduction: Preclinical Studies and Clinical Trials . Steven P. Vickers, Helen C. Jackson, Sharon C. Cheetham
, 2015
, Pages 90-116
Designing Multi-Target Drugs, Chapter 17 The Rational Design of Triple Reuptake Inhibitors for the Treatment of Depression . Robert J. Weikert
, 2012
, Pages 270-289
Flow Chemistry: Integrated Approaches for Practical Applications, Chapter 15 Automation of Flow Chemistry . Jonathan N. Jaworski, Rachel L. Beingessner, Timothy F. Jamison
, 2020
, Pages 461-484
Drug Discovery for Psychiatric Disorders, CHAPTER 8 Beyond SSRIs: Second-generation Reuptake Inhibitors for the Treatment of Depression . Peter T. Gallagher
, 2012
, Pages 184-225
Drug Discovery for Psychiatric Disorders, CHAPTER 14 Pharmacotherapies for Drug Addiction . C. D. Gipson, P. W. Kalivas
, 2012
, Pages 357-383
Forensic Chemistry of Substance Misuse: A Guide to Drug Control (2), CHAPTER 8 Structure-specific Generic Legislation
, 2022
, Pages 79-126
Toxicogenomics in Predictive Carcinogenicity, Chapter 10 Conazoles and Cancer: A Review . Stephen Nesnow
, 2016
, Pages 280-351
Chemical Warfare Toxicology: Volume 2: Management of Poisoning, Subject Index
, 2016
, Volume 2
, Pages 314-325
Chemical Warfare Toxicology: Volume 2: Management of Poisoning, CHAPTER 3 Nicotinic Receptors as Targets for Nerve Agent Therapy . John Tattersall
, 2016
, Volume 2
, Pages 82-119
Biophysical Techniques in Drug Discovery, Chapter 6 Characterization of Pharmaceutical Solids Combining NMR, X-ray diffraction and Computer Modelling . M. Sardo, I. C. B. Martins, C. Vladiskovic, M. Teresa Duarte, J. Rocha, N. Masciocchi, L. Mafra
, 2018
, Pages 120-169